Penn State Neuroscience Institute
Penn State Neuroscience Institute research includes the following departments and divisions:
Clinical trials are a key component in research:
- Active adult trials within the Neuroscience Institute.
- Active pediatric trials within the Neuroscience Institute.
Clinical trials - Who are they for? What do they do?
Clinical trials (or Clinical Research) is an organized way of looking at clinical information about patients and gaining new knowledge. The goal is always to find new and more effective ways of treating patients. Sometimes these trials involve the study of brand new treatments, or new combinations of old treatments, and sometimes these trials do not involve new treatments at all. At times, trials are designed to help understand if there is a difference in the way different people respond to the same treatment.
Why participate in a clinical trial?
Organized clinical research is the only way to gain new knowledge to improve the way sick patients are treated.
Read and subscribe to the Neuro Report blog
Penn State Neuroscience Institute offers a website dedicated to providing physicians with the latest in neuroscience news. Penn State Hershey Neuro Report publishes articles by our staff to share discoveries and successes. Read and subscribe to receive new articles as they are added to the blog.
Winter 2016 articles
- Penn State In The News: April 2016 In a monthly feature, Penn State’s Office of Strategic Communications features national and international news coverage of the work and expertise of Penn State’s faculty, students and staff.More...
- Penn State Stroke Center again earns highest level of designation The Penn State Stroke Center has once again earned a designation that recognizes the high level of care it provides to patients with the most severe and challenging types of strokes. Penn State Health Milton S. Hershey Medical Center is the only Comprehensive Stroke Center in central Pennsylvania.More...
- Patients with atrial fibrillation offered hope by new implantable device People with atrial fibrillation are most commonly treated with long-term use of blood-thinning medications to reduce the risk of a stroke. But a newly approved device now being implanted by physicians at Penn State Health Milton S. Hershey Medical Center offers many of those patients hope that they may be able to discontinue use of blood-thinners.More...
- Graduate student excellence celebrated at awards luncheon Penn State President Eric Barron presented 11 awards to more than 30 graduate students in recognition of outstanding achievement during the inaugural Graduate Student Awards Luncheon held April 27 at the Nittany Lion Inn.More...